Literature DB >> 8386739

Modulation of experimental hypersensitivity pneumonitis by Sendai virus.

Y Cormier1, E Israel-Assayag, M Fournier, G M Tremblay.   

Abstract

To evaluate the potential role of viruses in the pathogenesis of hypersensitivity pneumonitis (HP), we looked at the effect of challenging normal versus Sendai-injected mice with Saccharopolyspora rectivirgula (SR). In this model of HP, mice are nasally instilled with SR antigen three consecutive days per week of study. For this study virus was given after 3 weeks of SR. Two positive (SR alone, virus alone) and a negative (saline) control groups were done in parallel with the viral plus SR group. Lung response to these different conditions was evaluated by lung index, bronchoalveolar lavage (BAL) cell populations, lung histopathology, and BAL fluid fibronectin levels. SR challenge resulted in an increase in BAL cells, lung index, and BAL fibronectin levels and in a peribronchial inflammatory reaction. The virus alone produced a transient increase in BAL cells. The cellular response to SR, in virus-injected animals, was greater than the added effects of the virus and SR. Virus alone had no persistent effect on the other measured parameters and did not change the effect of SR on these variables. We conclude that the Sendai virus enhances the cellular response of the mouse lungs to an SR antigenic challenge.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8386739

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  7 in total

Review 1.  Natural pathogens of laboratory mice, rats, and rabbits and their effects on research.

Authors:  D G Baker
Journal:  Clin Microbiol Rev       Date:  1998-04       Impact factor: 26.132

2.  CD34 is required for dendritic cell trafficking and pathology in murine hypersensitivity pneumonitis.

Authors:  Marie-Renée Blanchet; Jami L Bennett; Matthew J Gold; Elena Levantini; Daniel G Tenen; Melissa Girard; Yvon Cormier; Kelly M McNagny
Journal:  Am J Respir Crit Care Med       Date:  2011-06-03       Impact factor: 21.405

3.  Viral infection enhances the response to Saccharopolyspora rectivirgula in mice prechallenged with this farmer's lung antigen.

Authors:  Y Cormier; N Samson; E Israël-Assayag
Journal:  Lung       Date:  1996       Impact factor: 2.584

4.  Hypersensitivity pneumonitis onset and severity is regulated by CD103 dendritic cell expression.

Authors:  Emilie Bernatchez; Anick Langlois; Julyanne Brassard; Nicolas Flamand; David Marsolais; Marie-Renée Blanchet
Journal:  PLoS One       Date:  2017-06-19       Impact factor: 3.240

5.  Non-culturable bioaerosols in indoor settings: Impact on health and molecular approaches for detection.

Authors:  Pascale Blais-Lecours; Phillipa Perrott; Caroline Duchaine
Journal:  Atmos Environ (1994)       Date:  2015-03-20       Impact factor: 4.798

6.  Novel acute hypersensitivity pneumonitis model induced by airway mycosis and high dose lipopolysaccharide.

Authors:  Yuying Zeng; Yun Zhang; Xinyan Huang; Lizhen Song; Katherine Polsky; Yifan Wu; Farrah Kheradmand; Yubiao Guo; Linda K Green; David B Corry; John M Knight
Journal:  Respir Res       Date:  2021-10-10

7.  Diagnosis of Hypersensitivity Pneumonitis in Adults. An Official ATS/JRS/ALAT Clinical Practice Guideline.

Authors:  Ganesh Raghu; Martine Remy-Jardin; Christopher J Ryerson; Jeffrey L Myers; Michael Kreuter; Martina Vasakova; Elena Bargagli; Jonathan H Chung; Bridget F Collins; Elisabeth Bendstrup; Hassan A Chami; Abigail T Chua; Tamera J Corte; Jean-Charles Dalphin; Sonye K Danoff; Javier Diaz-Mendoza; Abhijit Duggal; Ryoko Egashira; Thomas Ewing; Mridu Gulati; Yoshikazu Inoue; Alex R Jenkins; Kerri A Johannson; Takeshi Johkoh; Maximiliano Tamae-Kakazu; Masanori Kitaichi; Shandra L Knight; Dirk Koschel; David J Lederer; Yolanda Mageto; Lisa A Maier; Carlos Matiz; Ferran Morell; Andrew G Nicholson; Setu Patolia; Carlos A Pereira; Elisabetta A Renzoni; Margaret L Salisbury; Moises Selman; Simon L F Walsh; Wim A Wuyts; Kevin C Wilson
Journal:  Am J Respir Crit Care Med       Date:  2020-08-01       Impact factor: 30.528

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.